Eli Lilly Raises 2013 Guidance After Q2 Sales Rise

July 24 (Bloomberg) -- Eli Lilly & Co., the maker of the antidepressant Cymbalta and diabetes treatment Humalog, raised its full-year guidance after second-quarter sales grew faster than expected and cost-cutting programs took effect. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
The Growth of the Action Camera Market
35:32 - Ricoh Imaging's Jim Malcolm, iON Worldwide CEO Giovanni Tomaselli and 360fly CEO Peter Adderton discuss the growth of the action camera market with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Using Virtual Reality to Change the Face of Journalism
  • 360Fly: Pioneers of Spherical Video Market
  • Ricoh: The Future Potential for 360 Degree Cameras